These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 10677041

  • 1. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice.
    Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP, Unterwald E, Pasternak GW, Pintar JE.
    Neuron; 1999 Sep; 24(1):243-52. PubMed ID: 10677041
    [Abstract] [Full Text] [Related]

  • 2. Effects of multiple intracerebroventricular injections of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain delta-opioid receptors.
    Zhao GM, Bhargava HN.
    Brain Res; 1997 Jan 16; 745(1-2):243-7. PubMed ID: 9037415
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
    Bilsky EJ, Bernstein RN, Pasternak GW, Hruby VJ, Patel D, Porreca F, Lai J.
    Life Sci; 1994 Jan 16; 55(2):PL37-43. PubMed ID: 8015351
    [Abstract] [Full Text] [Related]

  • 4. Antisense mapping DOR-1 in mice: further support for delta receptor subtypes.
    Rossi GC, Su W, Leventhal L, Su H, Pasternak GW.
    Brain Res; 1997 Apr 04; 753(1):176-9. PubMed ID: 9125445
    [Abstract] [Full Text] [Related]

  • 5. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F, Heyman JS, Mosberg HI, Omnaas JR, Vaught JL.
    J Pharmacol Exp Ther; 1987 May 04; 241(2):393-400. PubMed ID: 3033214
    [Abstract] [Full Text] [Related]

  • 6. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Hruby VJ, Haaseth RC, Matsunaga TO, Porreca F.
    Eur J Pharmacol; 1994 Feb 03; 252(2):133-7. PubMed ID: 8157053
    [Abstract] [Full Text] [Related]

  • 7. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ, Bian JT, Bhargava HN.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):161-6. PubMed ID: 9369369
    [Abstract] [Full Text] [Related]

  • 8. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ, Bernstein RN, Hruby VJ, Rothman RB, Lai J, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr 24; 277(1):491-501. PubMed ID: 8613959
    [Abstract] [Full Text] [Related]

  • 9. Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse.
    Raffa RB, Martinez RP, Porreca F.
    Eur J Pharmacol; 1992 Jun 17; 216(3):453-6. PubMed ID: 1330585
    [Abstract] [Full Text] [Related]

  • 10. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug 17; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 11. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D, Bodnar RJ, Gistrak MA, Pasternak GW.
    Eur J Pharmacol; 1989 Sep 22; 168(3):307-14. PubMed ID: 2555205
    [Abstract] [Full Text] [Related]

  • 12. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ, Roerig SC, Fujimoto JM.
    J Pharmacol Exp Ther; 1991 Feb 22; 256(2):448-57. PubMed ID: 1847196
    [Abstract] [Full Text] [Related]

  • 13. Effects of competitive and noncompetitive antagonists of the N-methyl-D-aspartate receptor on the analgesic action of delta 1- and delta 2-opioid receptor agonists in mice.
    Bharagava HN, Zhao GM.
    Br J Pharmacol; 1996 Dec 22; 119(8):1586-90. PubMed ID: 8982505
    [Abstract] [Full Text] [Related]

  • 14. Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception.
    Kest B, Lee CE, Jenab S, Kao B, Inturrisi CE.
    Eur J Pharmacol; 1998 Mar 12; 345(1):47-53. PubMed ID: 9593593
    [Abstract] [Full Text] [Related]

  • 15. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
    Heyman JS, Mosberg HI, Porreca F.
    NIDA Res Monogr; 1986 Mar 12; 75():442-5. PubMed ID: 2828989
    [Abstract] [Full Text] [Related]

  • 16. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR, Tseng LF.
    Br J Pharmacol; 1999 Jan 12; 126(2):451-6. PubMed ID: 10077238
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of brain N-methyl-D-aspartate receptors following multiple intracerebroventricular injections of [D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin II in mice.
    Bhargava HN, Kumar S, Bian JT.
    Peptides; 1997 Jan 12; 18(10):1609-13. PubMed ID: 9437723
    [Abstract] [Full Text] [Related]

  • 18. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
    Fraser GL, Pradhan AA, Clarke PB, Wahlestedt C.
    J Pharmacol Exp Ther; 2000 Dec 12; 295(3):1135-41. PubMed ID: 11082450
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [D-Ala2, Glu4] deltorphin II, a delta 2-opioid receptor agonist in mice.
    Zhao GM, Bhargava HN.
    Peptides; 1996 Dec 12; 17(4):619-23. PubMed ID: 8804071
    [Abstract] [Full Text] [Related]

  • 20. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL, Mathiasen JR, Raffa RB.
    J Pharmacol Exp Ther; 1988 Apr 12; 245(1):13-6. PubMed ID: 2834533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.